Shopping Cart
Remove All
Your shopping cart is currently empty
Xanomeline tartrate (LY 246708 tartrate) is an M1 and M4 mAChR agonist with antipsychotic-like activity that improves cognition and can be used in studies of schizophrenia and Alzheimer's disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $30 | In Stock | In Stock | |
| 5 mg | $46 | In Stock | In Stock | |
| 10 mg | $64 | In Stock | In Stock | |
| 25 mg | $98 | In Stock | In Stock | |
| 50 mg | $148 | In Stock | In Stock | |
| 100 mg | $217 | In Stock | In Stock |
| Description | Xanomeline tartrate (LY 246708 tartrate) is an M1 and M4 mAChR agonist with antipsychotic-like activity that improves cognition and can be used in studies of schizophrenia and Alzheimer's disease. |
| In vitro | Xanomeline tartrate (LY 246708) (0.1-10 μM; CNS4U) shows an overall increase in average firing rate, indicating the functional presence of M1 receptors in hiPSC-derived neurons[1]. |
| In vivo | In Male Cebus apella monkeys, Xanomeline tartrate ( 0.5-3 mg / kg ; s.c. ; 1-3 hours ) can induce salivation and vomiting in some monkeys[3]. |
| Synonyms | LY-246708 tartrate, LY246708 tartrate, LY 246708 tartrate |
| Molecular Weight | 431.5 |
| Formula | C18H29N3O7S |
| Cas No. | 152854-19-8 |
| Smiles | O[C@@H]([C@H](O)C(O)=O)C(O)=O.CCCCCCOc1nsnc1C1=CCCN(C)C1 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | keep away from direct sunlight,keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (463.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (11.59 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.